Desq Long
Sign in

Company

Aktis Oncology, Inc.

AKTS · CIK 0002035832

SEC FORM 4
$61,875.00

Aktis Oncology, Inc. (AKTS)

Acquisition (code M) of 12,500 shares at $4.95 per share.

Reporting Person Czibere Akos · Officer Title Chief Medical Officer · Transaction Code M

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401014 · filed 2026-09-24 · View filing →

SEC FORM 4
$102,972.78

Aktis Oncology, Inc. (AKTS)

Sale of 5,099 shares at $20.1947 per share.

Reporting Person Czibere Akos · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401014 · filed 2026-09-24 · View filing →

SEC FORM 4
$155,648.21

Aktis Oncology, Inc. (AKTS)

Sale of 7,401 shares at $21.0307 per share.

Reporting Person Czibere Akos · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001193125-26-401014 · filed 2026-09-24 · View filing →